LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25

LIFECORE BIOMEDICAL, INC. DE

Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Aug 5, 2026

$6.39+0.01 (+0.16%)

Close on Oct 19, 2026

Community

Notes and questions about Lifecore Biomedical, Inc. De from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Lifecore Biomedical, Inc. De's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LFCR.

Revenue growth0.5% · median 13.2%

Gross margin31.3% · median 37.9%

Operating margin-13.4% · median 14.5%

Net margin-30.0% · median 16.4%

Advertisement
300 × 250